Shijiazhuang Yiling Pharmaceutical

Shijiazhuang Yiling Pharmaceutical

World Rank (Jan-05-2024)
2,708
Market Cap (Jan-05-2024)
5.516 Billion USD
World Rank (Jul-30-2023)
2,616
Market Cap (Jul-30-2023)
5.789 Billion USD
World Rank (Jan-07-2022)
2,931
Market Cap (Jan-07-2022)
5.773 Billion USD
World Rank (Jan-01-2021)
3,083
Market Cap (Jan-01-2021)
4.698 Billion USD
Company Rank in Country in 2023
Rank in China in July-2023 is 380
Headquarters Country
China
Market Cap (Mar-08-2026)
4.20
Employee Count
9,618
Employee Count as of Date
As on 2019
World Region
Asia
World Subregion
Eastern Asia
Annual Revenue in USD
1,756 Million USD
Annual Operating Income in USD
416 Million USD
Annual Net Income in USD
331 Million USD
Annual Results for Period Ending
Dec-2022 ending period
Total Assets in USD
2,289 Million USD
Total Liabilities in USD
758 Million USD
Total Equity in USD
1,532 Million USD
Balance Sheet for Period Ending
Dec-2022 ending period
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Biotechnology
Company Website
SHIJIAZHUANG YILING PHARMACEUTICAL
Yahoo
Yahoo @ Shenzhen
Company Profile
Shijiazhuang Yiling Pharmaceutical is a Leading Enterprise of Internalization of Preparation of Chinese Pharmaceutical Enterprise company. The company annual revenue is 885.04 million USD and 9,618 employees as on 2019. It is having more than 10 national patent Chinese medicine, 13 clinic permissions, over 20 preclinical permissions and hundreds of hospital preparations, covering major diseases fields as cardiovascular and cerebrovascular diseases, cold and respiratory diseases, tumors and diabetes. The headquarters is in China.
Stock Exchange
Shenzhen
Company SubCategory
Top Healthcare Companies in China

Share